|
|
Volumn 25, Issue 3, 2015, Pages 230-231
|
|
Active surveillance for favorable risk prostate cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
MOLECULAR MARKER;
RNA;
PROSTATE SPECIFIC ANTIGEN;
CANCER PATIENT;
CANCER PROGNOSIS;
CANCER STAGING;
DIAGNOSTIC TEST ACCURACY STUDY;
DISEASE SURVEILLANCE;
EDITORIAL;
GLEASON SCORE;
HUMAN;
METHYLATION;
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING;
OUTCOME ASSESSMENT;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SYSTEMATIC REVIEW (TOPIC);
BLOOD;
DIRECTIVE COUNSELING;
DISEASE COURSE;
MALE;
PROSTATIC NEOPLASMS;
WATCHFUL WAITING;
DIRECTIVE COUNSELING;
DISEASE PROGRESSION;
HUMANS;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
WATCHFUL WAITING;
|
|
EID: 84928573446
PISSN: 09630643
EISSN: 14736586
Source Type: Journal
DOI: 10.1097/MOU.0000000000000167 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
